Koutsoumanis Konstantinos, Allende Ana, Alvarez-Ordóñez Avelino, Bolton Declan, Bover-Cid Sara, Chemaly Marianne, Davies Robert, De Cesare Alessandra, Herman Lieve, Hilbert Friederike, Lindqvist Roland, Nauta Maarten, Ru Giuseppe, Simmons Marion, Skandamis Panagiotis, Suffredini Elisabetta, Andersson Dan I, Bampidis Vasileios, Bengtsson-Palme Johan, Bouchard Damien, Ferran Aude, Kouba Maryline, López Puente Secundino, López-Alonso Marta, Nielsen Søren Saxmose, Pechová Alena, Petkova Mariana, Girault Sebastien, Broglia Alessandro, Guerra Beatriz, Innocenti Matteo Lorenzo, Liébana Ernesto, López-Gálvez Gloria, Manini Paola, Stella Pietro, Peixe Luisa
EFSA J. 2021 Oct 26;19(10):e06865. doi: 10.2903/j.efsa.2021.6865. eCollection 2021 Oct.
The specific concentrations of trimethoprim in non-target feed for food-producing animals below which there would not be an effect on the emergence of, and/or selection for, resistance in bacteria relevant for human and animal health, as well as the specific antimicrobial concentrations in feed which have an effect in terms of growth promotion/increased yield were assessed by EFSA in collaboration with EMA. Details of the methodology used for this assessment, associated data gaps and uncertainties, are presented in a separate document. To address antimicrobial resistance, the Feed Antimicrobial Resistance Selection Concentration (FARSC) model developed specifically for the assessment was applied. The FARSC for trimethoprim was estimated. Uncertainties and data gaps associated to the levels reported were addressed. To address growth promotion, data from scientific publications obtained from an extensive literature review were used. No suitable data for the assessment were available. It was recommended to perform further studies to supply more diverse and complete data related to the requirements for calculation of the FARSC for trimethoprim.
欧洲食品安全局(EFSA)与欧洲药品管理局(EMA)合作,评估了甲氧苄啶在产食用动物非靶标饲料中的特定浓度,低于该浓度不会对与人类和动物健康相关细菌的耐药性产生和/或选择产生影响,以及饲料中具有促进生长/提高产量作用的特定抗菌浓度。用于该评估的方法细节、相关数据缺口和不确定性在一份单独文件中呈现。为应对抗菌药物耐药性问题,应用了专门为该评估开发的饲料抗菌药物耐药性选择浓度(FARSC)模型。估算了甲氧苄啶的FARSC。处理了与报告水平相关的不确定性和数据缺口。为解决生长促进问题,使用了通过广泛文献综述从科学出版物中获得的数据。没有可用于评估的合适数据。建议开展进一步研究,以提供与计算甲氧苄啶FARSC要求相关的更多样化和完整的数据。